Hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme

K. Tsuboi, M. Mizumoto, T. Tsurubuchi, T. Yamamoto, T. Okumura, H. Sakurai & T. Sakae
Background:In this study the safety and efficacy of postoperative hyperfractionated concomitant boost proton beam (PB) radiotherapy for supratentorial glioblastoma multiforme (GBM) were prospectively evaluated. In addition, the chronological changes of gadolinium-enhanced volume (EV) on MRI and immuno[for full text, please go to the a.m. URL]